Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Biotech May Soon Sell Vaccine to International Aid Groups

publication date: Oct 4, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Biotech Group (CNBG) vaccine for Japanese encephalitis is about to be the first vaccine from China approved for use by the World Health Organization (WHO). Once the vaccine is awarded “prequalification status,” NGOs such as the Global Alliance for Vaccines and Immunization (GAVI) can purchase it for distribution in less-developed areas as the world. The Chengdu Institute, one of China Biotech’s subsidiaries, developed and produces the vaccine. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners